Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| WeDoctor | 2021 | Series F | $411.0M | Xiaoshan |
| RFoneTech | 2021 | Series A | $4.6M | Nanjing |
| Kira Pharmaceuticals | 2021 | Series B | $53.5M | Hong Kong |
| Bioscience | 2021 | Series Unknown | $8.0M | Tianjin |
| TutorEva | 2021 | Series Unknown | $20.0M | Singapore |
| Compart Systems | 2020 | Series Unknown | $398.0M | Gainsborough |
| Transwarp | 2020 | Series E | $45.8M | Xuhui |
| Asieris Pharmaceuticals | 2020 | Series D | $105.6M | Shanghai |
| InventisBio | 2020 | Series D | $147.0M | Shanghai |
| Antengene | 2020 | Series C | $97.0M | Shanghai |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 276 | WeDoctor | Series F | $411.0M | Xiaoshan, China |
| 277 | RFoneTech | Series A | $4.6M | Nanjing, China |
| 278 | Kira Pharmaceuticals | Series B | $53.5M | Hong Kong, Hong Kong |
| 279 | Bioscience | Series Unknown | $8.0M | Tianjin, China |
| 280 | TutorEva | Series Unknown | $20.0M | Singapore, Singapore |
| 281 | Compart Systems | Series Unknown | $398.0M | Gainsborough, United Kingdom |
| 282 | Transwarp | Series E | $45.8M | Xuhui, China |
| 283 | Asieris Pharmaceuticals | Series D | $105.6M | Shanghai, China |
| 284 | InventisBio | Series D | $147.0M | Shanghai, China |
| 285 | Antengene | Series C | $97.0M | Shanghai, China |
WeDoctor is a medical health technology platform that offers online services for hospitals and doctors on-site.
RFoneTech is a semiconductor company that offers electronic components and services.
Kira Pharmaceuticals is a Biotechnology Research Company.
Bioscience is engaged in the research and development of an automatic medical inspection line.
TutorEva is an online app through which users scan arithmetic problems and receive solutions in the form of text, illustrations etc.
Compart Systems is a global strategic supplier of high-precision flow control products and technologies.
Transwarp develops big data software technologies for enterprises.
Asieris Pharmaceuticals is a Chinese biotech company.
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.
Your unified data lake and analysis platform for 5G
61Draw.com is an online children¡¯s art education platform.
DiNovA Medtech develops vascular intervention technology for the treatment of aneurysm.
Wuli Planet is a social and game app for young people.
Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.
NVX Clouds Tech is an artificial intelligence security computing company focused on data privacy protection.
Chushou TV is a mobile video live streaming platform specialized in mobile games.
Xiudan is a multiplayer video interaction app.
Inbilin is a Voice call app company
Chaodian Culture is a brokerage firm that provides in cultural brand of the bilibili video screen network.
Liuyi Jiaoyu is an online children's quality education company.
Club Factory is a cross-border e-commerce corporation.
QwikMatch is a mobile Internet company focused on gaming social platforms.
MyHealthTeams creates social networks for chronic condition communities.
Qiming Venture Partners has invested in 370 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Medical, Health Care, Biotechnology, Internet, Pharmaceutical. The firm invests across 42 different industry categories.
Among tracked funding rounds, WeDoctor received $411.0M in a Series F round. Qiming Venture Partners's total known invested capital is $11.0B.
Qiming Venture Partners's average investment size is $54.4M across its portfolio of 370 companies.
Recent Qiming Venture Partners portfolio additions include WeDoctor, RFoneTech, Kira Pharmaceuticals, Bioscience, TutorEva. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors